Healthcare & Life Sciences
Avalo Therapeutics
United Stateswww.linkedin.com/company/avalotx/
alivepre-ipo
pre-ipo
Stage
1
Investors
About
Avalo Therapeutics is a clinical stage biotechnology company developing novel IL-1β targeting therapies for immune-mediated inflammatory diseases such as hidradenitis suppurativa.
Explore Avalo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.